China Animal Vaccine Industry Report, 2012-2015

Publisher Name :
Date: 4-Jun-2013
No. of pages: 128
Inquire Before Buying

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian influenza, highly pathogenic PRRS (porcine reproductive and respiratory syndrome), classical swine fever and peste des petits ruminants in the national compulsory immunization coverage following the FMD (foot-and-mouth disease), thus leading to rapid growth in animal vaccine market size.

In 2004-2012, China’s animal vaccine market size grew at a CAGR as high as 26.4%, up to approximately RMB 9.1 billion in 2012 (including net import). For years to come, the market is expected to continue to maintain a growth rate of 15% or so, to RMB 15.9 billion in 2016.

Chinese animal vaccine products include swine vaccine, poultry vaccine, cattle & sheep vaccine, pet and other vaccines. As pig and poultry breeding is the core of China’s animal husbandry, swine and poultry vaccines account for more than 85% of China’s animal vaccine market. In addition, the emerging pet industry is boosting vigorous growth in demand for pet vaccine, while there are few commercial pet vaccines from Chinese animal vaccine companies, mainly dependent on imported products with stiff prices. In future, the Chinese pet vaccine market will usher in large room for promotion.

In 2006, China carried out compulsory veterinary drug GMP certification, raised the industry access threshold, which brought a substantial decline in the number of animal vaccine enterprises, accompanied by increased industry concentration. In 2012, among domestic leading animal vaccine enterprises, China Animal Husbandry Industry Co., Ltd. made the highest animal vaccine revenue of RMB 1.17 billion, with market occupancy up to 12.9%; followed by Qingdao Yebio Bioengineering Co., Ltd (Zhejiang Shenghua Biok Biology Co., Ltd holds 38% stake), Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd., Inner Mongolia Jinyu Group Stock Company, etc.

The Chinese animal vaccine market can be divided into two segments, i.e. government-procured compulsory immunization vaccines and market-oriented vaccines. Currently, there are merely five kinds of compulsory immunization vaccines, and more vaccines are market-oriented. However, in China, compulsory immunization vaccines still hold a market share of over 50%, with highly fierce competition but limited growth potential; by contrast, market-oriented vaccines will enjoy a larger space for development no matter in new product development or in animal protection improvement.

China Animal Vaccine Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:

  • Market size, market structure, competition pattern, etc. of global animal vaccine industry;
  • Market size, market structure, competition pattern, import & export, etc. of China animal vaccine industry;
  • Policy environment, social environment, downstream demand, etc. of China animal vaccine industry;
  • Scale & structure prediction for China animal vaccine market and market segments;
  • Operation, animal vaccine business, forecast & outlook, etc. of 10 animal vaccine producers in China.

China Animal Vaccine Industry Report, 2012-2015

Table of Contents

1. Overview of Animal Vaccine Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development Status of Animal Vaccine Industry
2.1 Status of International Animal Vaccine Industry
2.1.1 Market Size
2.1.2 Market Structure
2.1.3 Competition Pattern
2.1.4 New Diseases and New Products
2.2 Status of China Animal Vaccine Industry
2.2.1 Market Size
2.2.2 Market Structure
2.2.3 Import & Export
2.2.4 Profit Level
2.2.5 Entry Barriers
2.2.6 Competition Pattern

3. Development Environment of China Animal Vaccine Industry
3.1 Policy Environment
3.1.1 Major Policies
3.1.2 Compulsory Immunization Vaccine Tender System
3.2 Social Environment
3.2.1 Breeding Industry is Developing Steadily
3.2.2 Large-scale Breeding Becomes a Trend
3.2.3 Animal Epidemics Occur Frequently

4. Development Forecast of China Animal Vaccine Industry
4.1 Overall Forecast
4.2 Swine Vaccine
4.2.1 Swine Fever Vaccine
4.2.2 FMD Vaccine
4.2.3 PRRS Vaccine
4.2.4 Porcine Circovirus Vaccine
4.3 Poultry Vaccine
4.4 Cattle & Sheep Vaccine
4.5 Pet Vaccine

5. Key Companies in China Animal Vaccine Industry
5.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Animal Vaccine Business
5.1.6 Forecast & Outlook
5.2 Inner Mongolia Jinyu Group Stock Company
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D
5.2.6 Animal Vaccine Business
5.2.7 Forecast & Outlook
5.3 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D
5.3.6 Clients & Suppliers
5.3.7 Animal Vaccine Business
5.3.8 Forecast & Outlook
5.4 Ningbo TECH-BANK Co., Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D
5.4.6 Animal Vaccine Business
5.4.7 Forecast & Outlook
5.5 Zhejiang Shenghua Biok Biology Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Clients
5.5.6 Animal Vaccine Business
5.5.7 Forecast & Outlook
5.6 Chengdu Huasun Group Inc. Ltd.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Clients & Suppliers
5.6.6 Animal Vaccine Business
5.7 Tianjin Ringpu Bio-technology Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R&D
5.7.6 Animal Vaccine Business
5.7.7 Forecast & Outlook
5.8 Guangdong Dahuanong Animal Health Products Co., Ltd. (DHN)
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Gross Margin
5.8.5 R&D
5.8.6 Animal Vaccine Business
5.8.7 Forecast & Outlook
5.9 Liaoning Yikang Biological Corporation Limited
5.9.1 Profile
5.9.2 Operation
5.9.3 Revenue Structure
5.9.4 Gross Margin
5.9.5 R&D
5.9.6 Clients & Suppliers
5.9.7 Animal Vaccine Business
5.10 Wuhan Chopper Biology Co., Ltd.
5.10.1 Profile
5.10.2 Operation
5.10.3 Revenue Structure
5.10.4 Gross Margin
5.10.5 R&D
5.10.6 Clients & Suppliers
5.10.7 Animal Vaccine Business

List of Charts

Animal Health Product Classification
Animal Vaccine Types (by Constituent and Property) and Features
Animal Vaccine Industry Chain
China Animal Disease Classification
Global Animal Vaccine Market Size, 2008-2016E
Basic Information of Global Animal Health Product Industry Giants
Foreign Commercial Vaccines and Producers Over the Years
China Animal Vaccine Market Size, 2000-2012
China Animal Vaccine Product Structure by Animal Attribute, 2008-2012
China Animal Vaccine Market Structure by Sales Method
Compulsory Immunization Vaccine Product Producers in China, 2012
China Commercial Vaccine Classification and Market Situation
Import / Export Volume of Veterinary Vaccine in China, 2008-2013
Average Import / Export Price of Veterinary Vaccine in China, 2008-2013
China Veterinary Vaccine Import Countries by Import Volume, 2012
China Veterinary Vaccine Export Destination Distribution by Export Volume, 2012
China Veterinary Vaccine Import Areas and % of Import Volume, 2012
China Veterinary Vaccine Export Areas and % of Export Volume, 2012
Gross Margin of Animal Vaccine Business of Leading Animal Vaccine Listed Companies in China, 2011-2012
Barriers to Enter China Animal Vaccine Industry
Main Products of Leading Animal Vaccine Producers in China, 2012
Revenue of Animal Vaccine Business of Major Animal Vaccine Listed Companies in China, 2011-2012
Major Gaps between Chinese Vaccine Production Technology Level and International Advanced Level
Sino-foreign Animal Vaccine Joint Ventures, 1990-2012
Major Policies on Animal Vaccine Industry in China, 2010-2013
National Animal Disease Compulsory Immunization Program in 2013
Animal Diseases with Priority to Prevention and Cure in China, 2013-2020
Defects of China’s Compulsory Immunization Tender System
Direction for China’s Compulsory Immunization Tender System Reform
Meat, Eggs and Milk Output in China, 2008-2012
Per Capita Consumption of Pork, Beef and Mutton in China, 2008-2012
China Meat Product Structure by Output, 2010-2012
Level of Large-scale Breeding in China, 2010-2020
Epidemic Prevention Costs of Pig Breeding in China, 2008-2012
Overview of Common Animal Epidemics in China
China Animal Epidemic Summary, 2013
China Animal Vaccine Market Size, 2012-2016E
China Animal Vaccine Market Structure by Animal Attribute, 2012 vs. 2016E
Hog Breeding Stock and Slaughter in China, 2000-2012
China Swine Vaccine Market Size, 2012-2016E
Performance Comparison of Various Swine Fever Vaccines in China
China Poultry Vaccine Market Size, 2012-2016E
Newcastle Disease Vaccine Market Capacity and Ringpu Biology’s Market Share
China Cattle & Sheep Vaccine Market Size, 2012-2016E
China’s Per Capita GDP by Province/City, 2012
China Pet Vaccine Market Size, 2012-2016E
China Pet Vaccine Market Supply Companies
Revenue and Net Income of CAHIC, 2008-2012
Revenue Breakdown of CAHIC by Product, 2010-2012
Revenue Structure of CAHIC by Product, 2010-2012
Revenue Breakdown of CAHIC by Region, 2010-2012
Revenue Structure of CAHIC by Region, 2010-2012
Gross Margin of Main Products of CAHIC, 2010-2012
Animal Vaccine Capacity Layout of CAHIC
Animal Vaccine Projects under Construction of CAHIC, 2013
Revenue and Net Income of CAHIC, 2011-2015E
Revenue and Net Income of Jinyu Group, 2008-2012
Revenue Breakdown of Jinyu Group by Product, 2010-2012
Revenue Structure of Jinyu Group by Product, 2010-2012
Revenue Breakdown of Jinyu Group by Region, 2010-2012
Revenue Structure of Jinyu Group by Region, 2010-2012
Gross Margin of Main Business of Jinyu Group, 2010-2012
R&D Costs and % of Total Revenue of Jinyu Group, 2010-2012
Animal Vaccine-related Subsidiaries of Jinyu Group, 2012
Revenue and Net Income of Jinyu Group, 2011-2015E
Revenue and Net Income of Tecon, 2008-2012
Revenue Breakdown of Tecon by Product, 2010-2012
Revenue Structure of Tecon by Product, 2010-2012
Revenue Breakdown of Tecon by Region, 2010-2012
Revenue Structure of Tecon by Region, 2010-2012
Gross Margin of Main Products of Tecon, 2010-2012
R&D Costs and % of Total Revenue of Tecon, 2010-2012
Tecon’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Tecon’s Top 5 Clients, 2012
Tecon’s Procurement from Top 5 Suppliers and % of Total Procurement, 2012
Progress of Animal Vaccine R&D Projects of Tecon, 2012
Revenue and Net Income of Tecon, 2011-2015E
Revenue and Net Income of TECH-BANK, 2008-2012
Revenue Breakdown of TECH-BANK by Product, 2010-2012
Revenue Structure of TECH-BANK by Product, 2010-2012
Revenue Breakdown of TECH-BANK by Region, 2010-2012
Revenue Structure of TECH-BANK by Region, 2010-2012
Gross Margin of Main Products of TECH-BANK, 2010-2012
R&D Costs and % of Total Revenue of TECH-BANK, 2010-2012
Revenue and Net Income of Chengdu TECBOND Biological Products, 2010-2012
Revenue and Net Income of TECH-BANK, 2011-2015E
Revenue and Net Income of Shenghua Biok, 2008-2012
Revenue Breakdown of Shenghua Biok by Product, 2010-2012
Revenue Structure of Shenghua Biok by Product, 2010-2012
Revenue Breakdown of Shenghua Biok by Region, 2010-2012
Revenue Structure of Shenghua Biok by Region, 2010-2012
Gross Margin of Main Products of Shenghua Biok, 2010-2012
Shenghua Biok’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Shenghua Biok’s Top 5 Clients, 2012
Revenue and Net Income of Qingdao Yebio Bioengineering, 2008-2012
Revenue and Net Income of Shenghua Biok, 2011-2015E
Revenue and Net Income of Huasun Group, 2008-2012
Revenue Breakdown of Huasun Group by Product, 2010-2012
Revenue Structure of Huasun Group by Product, 2010-2012
Revenue Breakdown of Huasun Group by Region, 2010-2012
Revenue Structure of Huasun Group by Region, 2010-2012
Gross Margin of Main Products of Huasun Group, 2010-2012
Huasun Group’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Huasun Group’s Top 5 Clients, 2012
Huasun Group’s Procurement from Top 5 Suppliers and % of Total Procurement, 2010-2012
Name List and Procurement Contribution of Huasun Group’s Top 5 Suppliers, 2012
Revenue and Net Income of Ringpu Bio-technology, 2008-2012
Revenue Breakdown of Ringpu Bio-technology by Product, 2010-2012
Revenue Structure of Ringpu Bio-technology by Product, 2010-2012
Revenue Breakdown of Ringpu Bio-technology by Region, 2010-2012
Revenue Structure of Ringpu Bio-technology by Region, 2010-2012
Gross Margin of Main Products of Ringpu Bio-technology, 2010-2012
R&D Costs and % of Total Revenue of Ringpu Bio-technology, 2008-2012
Output and Sales Volume of Animal Vaccine Products of Ringpu Bio-technology, 2011-2012
Sales and Gross Margin of Animal Vaccine of Ringpu Bio-technology by Product, 2012
Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
Revenue and Net Income of Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
Progress of Animal Vaccine-related Projects of Ringpu Bio-technology, 2012
Revenue and Net Income of Ringpu Bio-technology, 2011-2015E
Revenue and Net Income of Dahuanong, 2008-2012
Revenue Breakdown of Dahuanong by Product, 2010-2012
Revenue Structure of Dahuanong by Product, 2010-2012
Revenue Breakdown of Dahuanong by Region, 2010-2012
Revenue Structure of Dahuanong by Region, 2010-2012
Gross Margin of Main Products of Dahuanong, 2010-2012
R&D Costs and % of Total Revenue of Dahuanong, 2010-2012
Output, Sales Volume and Sales-Output Ratio of Veterinary Biological Products of Dahuanong, 2011-2012
Progress of Animal Vaccine-related Projects of Dahuanong by end-2012
Revenue and Net Income of Dahuanong, 2011-2015E
Revenue and Net Income of Yikang Biological, 2009-2011
Revenue Breakdown of Yikang Biological by Product, 2009-2011
Revenue Structure of Yikang Biological by Product, 2009-2011
Revenue Breakdown of Yikang Biological by Region, 2009-2011
Revenue Structure of Yikang Biological by Region, 2009-2011
Gross Margin of Main Products of Yikang Biological, 2009-2011
R&D Costs and % of Total Revenue of Yikang Biological, 2009-2011
Yikang Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of Yikang Biological’s Top 5 Clients, 2011
Yikang Biological’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of Yikang Biological’s Suppliers, 2011
Animal Vaccine Production Lines of Yikang Biological, 2009-2011
Capacity, Output and Capacity Utilization of Yikang Biological, 2009-2011
Output, Sales Volume and Sales-Output Ratio of Yikang Biological, 2009-2011
Average Sales Price of Main Products of Yikang Biological, 2009-2011
Revenue Structure of Yikang Biological by Sales Model, 2009-2011
Revenue and Net Income of Chopper Biology, 2009-2011
Revenue Breakdown of Chopper Biology by Product, 2009-2011
Revenue Structure of Chopper Biology by Product, 2009-2011
Revenue Breakdown of Chopper Biology by Region, 2009-2011
Revenue Structure of Chopper Biology by Region, 2009-2011
Gross Margin of Main Products of Chopper Biology, 2009-2011
R&D Costs and % of Total Revenue of Chopper Biology, 2009-2011
Chopper Biology’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of Chopper Biology’s Top 5 Clients, 2011
Sales Contract between Chopper Biology and Animal Husbandry and Veterinary Bureau of Hubei Province, 2011
Chopper Biology’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of Chopper Biology’s Suppliers, 2011
Sales of Major Vaccine Products of Chopper Biology, 2009-2011
Vaccine Capacity, Output and Capacity Utilization of Chopper Biology, 2009-2011
Vaccine Output, Sales Volume and Sales-Output Ratio of Chopper Biology, 2009-2011
Average Sales Price of Major Vaccine Products of Chopper Biology, 2009-2011
Investment Plan of Chopper Biology, 2012

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global Polymerase Chain Reaction (PCR) Market 2014-2018
    Published: 29-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Polymerase Chain Reaction (PCR) is a technique of molecular genetics, which allows amplification and analysis of nucleic acid. It is very precise, specific and accurate technique used to amplify a specific DNA target from a mixture of DNA molecules. It is used in a wide array of applications in research and diagnosis, including genetic engineering, cloning, sequencing, diagnosis, genotyping, and many other areas. Advances in PCR technology and tools provide high reproducibility within a short pe......
  • RNA Interference Screening Trends 2014
    Published: 27-Oct-2014        Price: US $2500 Onwards        Pages: 53
    Executive Summary This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on RNA interference (RNAi) screening and gene silencing carried out in October 2014. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update our previous report in siRNA screening (published September 2012). The questionnaire was compiled to meet the needs, requirements and interests of the RNAi screening vendo......
  • DiscoveryBiomed, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 24
    DiscoveryBiomed, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘DiscoveryBiomed, Inc. - Product Pipeline Review - 2014', provides an overview of the DiscoveryBiomed, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of DiscoveryBiomed, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route......
  • TVAX Biomedical, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 29
    TVAX Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘TVAX Biomedical, Inc. - Product Pipeline Review - 2014', provides an overview of the TVAX Biomedical, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of TVAX Biomedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route......
  • Medisyn Technologies, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 29
    Medisyn Technologies, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Medisyn Technologies, Inc. - Product Pipeline Review - 2014', provides an overview of the Medisyn Technologies, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Medisyn Technologies, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of......
  • GlycoVaxyn AG – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 30
    GlycoVaxyn AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘GlycoVaxyn AG - Product Pipeline Review - 2014', provides an overview of the GlycoVaxyn AG's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoVaxyn AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and mol......
  • Biomay AG – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 33
    Biomay AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Biomay AG - Product Pipeline Review - 2014', provides an overview of the Biomay AG's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Biomay AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It a......
  • Vaxart, Inc. – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 31
    Vaxart, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Vaxart, Inc. - Product Pipeline Review - 2014', provides an overview of the Vaxart, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxart, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecul......
  • Immunocore Limited – Product Pipeline Review – 2014
    Published: 25-Oct-2014        Price: US $1500 Onwards        Pages: 31
    Immunocore Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Immunocore Limited - Product Pipeline Review - 2014', provides an overview of the Immunocore Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Immunocore Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs